10 Best Performing Leveraged ETFs in 2022

Published on December 13, 2022 at 6:47 pm by Omer Farooq in ETF Trading, News

In this article, we will discuss the 10 best performing leveraged ETFs in 2022. If you want to explore similar ETFs, you can also take a look at 5 Best Performing Leveraged ETFs in 2022.

What Are Leveraged ETFs?

Leveraged ETFs are exchange–traded funds that use financial derivatives and debt to amplify the returns of an underlying index. They are designed to provide investors with a high degree of exposure to a particular asset class or market segment. Unlike traditional ETFs, leveraged ETFs are designed to magnify the return of the underlying index. They do this by using derivatives such as options and futures contracts, as well as borrowing money to increase the size of their portfolio. This can lead to amplified gains, but also amplified losses.

It’s a Two Way Street

Let’s take an example to understand the behavior of a leveraged ETF. A 3x leveraged ETF seeks to deliver three times the daily performance of the underlying index. So, if the underlying index rises 1%, the ETF will rise 3%. Conversely, if the underlying index falls 1%, the ETF would decline 3%. Leveraged ETFs are a popular tool for traders and investors who want to take advantage of short–term price movements. Leveraged ETFs can also be used to hedge against market volatility or to diversify a portfolio. However, investing in leveraged ETFs carries a high degree of risk by nature, and investors should evaluate their risk tolerance before exploring this instrument.

By design, leveraged ETFs are more suitable for day traders or investors with a short-term time horizon. For investors that do not have the risk tolerance for trading leveraged ETFs, they can opt for individual stocks that are among these funds’ holdings. Some of the most popular long-term stocks among elite money managers and also present in leveraged ETFs include Johnson & Johnson (NYSE:JNJ), Northrop Grumman Corporation (NYSE:NOC), and ConocoPhillips (NYSE:COP).

Photo by Behnam Norouzi on Unsplash

Our Methodology

To determine the best performing leveraged ETFs in 2022, we screened for leveraged ETFs with varying ratios including 1.25, 1.5x, 2x, and 3x. We reviewed these ETFs’ year-to-date performance, as of December 9, and narrowed down our selection to the best performing leveraged ETFs. We used the S&P 500 as a benchmark to compare the performance of each ETF. Though some of them are down, they are not down as much as the S&P 500, which closed a little above 3,900 on December 9 and is down more than 18% for the year.

Along with each ETF, we have mentioned its leverage ratio, the index it tracks, the technique it uses, its portfolio breakdown, and most notable holdings. These ETFs are ranked in increasing order of their year-to-date performance.

Best Performing Leveraged ETFs in 2022

10. ProShares Ultra Basic Materials (NYSEARCA:UYM)

Leverage: 2x

YTD Return as of December 9: -17.81%

The ProShares Ultra Basic Materials (NYSEARCA:UYM) invests directly and through derivatives in stocks that belong to the materials sector. The fund aims to deliver 2x the daily performance of the Dow Jones U.S. Basic Materials Index and employs a full replication technique. The fund has an expense ratio of 0.95% and a yield of 0.75%. As of December 9, the ProShares Ultra Basic Materials (NYSEARCA:UYM) has lost 17.81% year to date, outperforming the S&P 500 by roughly 1%, and is placed on our list of the best performing leveraged ETFs in 2022.

The ProShares Ultra Basic Materials (NYSEARCA:UYM) has roughly $47.4 million in assets under management and 53 holdings. The fund has a top ten holdings concentration of 149.40%. One of the fund’s top ten holdings is Linde plc (NYSE:LIN). The stock has surged more than 11% over the past six months, as of December 9.

On October 31, Deutsche Bank analyst David Begleiter raised his price target on Linde plc (NYSE:LIN) to EUR 355 from EUR 350 and maintained a Buy rating on the shares.

As of September 30, Impax Asset Management is the largest shareholder in Linde plc (NYSE:LIN) and has a position worth $816.9 million.

Here is what ClearBridge Investments had to say about Linde plc (NYSE:LIN) in its third-quarter 2022 investor letter:

“Seeing better opportunities elsewhere in the materials sector, we exited our position in Ecolab and added to copper producer Freeport-McMoRan (FCX), which supplies a much-needed resource for the energy transition, and specialty chemical company Linde plc (NYSE:LIN), which has historically held onto pricing gains it has achieved following increases in energy costs. We think this pricing power should protect profitability during the acute inflationary phase and potentially lead to margin expansion when cost pressures abate. Linde also continues to be well-positioned on hydrogen and carbon capture with contract-backed project capex likely accelerating in the medium term as the recently passed Inflation Reduction Act rolls out.”

In addition to Johnson & Johnson (NYSE:JNJ), Northrop Grumman Corporation (NYSE:NOC), and ConocoPhillips (NYSE:COP), Linde plc (NYSE:LIN) is also a stock that is popular among elite money managers.

9. Direxion Daily Healthcare Bull 3X Shares (NYSEARCA:CURE)

Leverage: 3x

YTD Return as of December 9: -16.92%

The Direxion Daily Healthcare Bull 3X Shares (NYSEARCA:CURE) uses derivatives, such as futures, or other funds to invest in stocks of companies operating in the healthcare sector. The fund invests in large-cap stocks and aims to deliver 3 times the daily return of the Health Care Select Sector Index. The fund has declined by 16.92% year to date, as of December 9, and has outperformed the S&P 500 by roughly 2%. The Direxion Daily Healthcare Bull 3X Shares (NYSEARCA:CURE) is one of the best performing leveraged ETFs in 2022.

The Direxion Daily Healthcare Bull 3X Shares (NYSEARCA:CURE) has $228.65 million in assets under management and an expense ratio of 0.96%. The fund has a trailing twelve-month yield of 0.27% and pays out dividends on a quarterly basis. The fund has 68 holdings and a top ten holdings concentration of 74.17%.

One of the top holdings of the Direxion Daily Healthcare Bull 3X Shares (NYSEARCA:CURE) is Thermo Fisher Scientific Inc. (NYSE:TMO). This December, RBC Capital analyst Conor McNamara started coverage of Thermo Fisher Scientific Inc. (NYSE:TMO) with an Outperform rating and a $661 price target. As of December 9, the stock has returned 10% to investors over the past six months.

As of September 30, Ken Fisher’s Fisher Asset Management is the dominant investor in Thermo Fisher Scientific Inc. (NYSE:TMO) and has a position worth $1.16 billion in the company.

Here is what Aristotle Atlantic Partners, LLC had to say about Thermo Fisher Scientific Inc. (NYSE:TMO) in its third-quarter 2022 investor letter:

“Thermo Fisher Scientific Inc. (NYSE:TMO) is considered one of the world’s leaders in serving science. The company makes and distributes analytical instruments, scientific equipment, consumables and other laboratory supplies. Thermo Fisher Scientific operates in four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics and Laboratory Product and Biopharma Services. We see Thermo Fisher Scientific as one of the leading management teams in our coverage both through solid execution and savvy Mergers & Acquisitions (M&A). The company is a diversified provider of research and discovery instruments, tools, consumables, and services, and offers a broad-based play on the increased Research & Development (R&D) spend from the biopharma industry. Thermo Fisher Scientific continues to see organic growth in the high single digits with acquisitions increasing their overall portfolio composition and gaining market share.”

8. Direxion Daily Utilities Bull 3X Shares (NYSEARCA:UTSL)

Leverage: 3x

YTD Return as of December 9: -13.87%

The Direxion Daily Utilities Bull 3X Shares (NYSE:UTSL) has an expense ratio of 0.96% and a yield of 1.73%. The ETF is designed to deliver 3x the daily returns of the Utilities Select Sector Index. The fund makes use of derivatives such as futures and swaps to structure its portfolio and invests in utilities stocks of diverse market caps. As of December 9, the fund has lost 13.87% year to date and has outperformed the S&P 500 by approximately 4%. The fund is one of the best performing leveraged ETFs in 2022.

The Direxion Daily Utilities Bull 3X Shares (NYSE:UTSL) has $22.73 million in assets under management and has 35 holdings. The fund has a top ten holdings concentration of 85.36%. Exelon Corporation (NASDAQ:EXC) is one of the top holdings of the fund. The stock has gained 7% over the past twelve months, as of December 9, and is offering a dividend yield of 3.26%.

On October 3, Credit Suisse analyst Nicholas Campanella started coverage of Exelon Corporation (NASDAQ:EXC) with an Outperform rating and a $43 price target.

As of the close of Q3 2022, GQG Partners is the top shareholder in Exelon Corporation (NASDAQ:EXC) and has disclosed stakes worth $800 million in the company.

7. ProShares Ultra Health Care (NYSEARCA:RXL)

Leverage: 2x

YTD Return as of December 9: -13.05%

The ProShares Ultra Health Care (NYSEARCA:RXL) has fallen by 13.05% year to date, as of December 9, but is one of the best performing leveraged ETFs in 2022 since it has outperformed the S&P 500 by roughly 5%. The fund aims to deliver twice the daily returns of the Dow Jones U.S. Health Care Index by using a full replication technique. The fund populates its portfolio by using derivates, such as swaps. The fund has an expense ratio of 0.95%.

The ProShares Ultra Health Care (NYSEARCA:RXL) has 162 holdings and a top ten holdings concentration of 143.99%. The fund’s assets under management are valued at $109.17 million. One of the fund’s top holdings is AbbVie Inc. (NYSE:ABBV). This November, Credit Suisse analyst Trung Huynh took coverage of AbbVie Inc. (NYSE:ABBV) with an Outperform rating and a $170 price target. The analyst also called it one of his top ideas in the large-cap biopharma space.

As of September 30, Arrowstreet Capital is the largest investor in AbbVie Inc. (NYSE:ABBV) and has a position worth $431.6 million. As of December 9, AbbVie Inc. (NYSE:ABBV) has gained over 20% year to date and is offering a forward dividend yield of 3.63%.

Here is what Baron Funds had to say about AbbVie Inc. (NYSE:ABBV) in its third-quarter 2022 investor letter:

“AbbVie Inc. (NYSE:ABBV) is a drug developer best known for Humira, an immunosuppressant that is the best selling drug of all time. Given outsized key product risk (patent cliff and generic launches beginning in 2023), AbbVie has broadened its pipeline, highlighted by its Allergan acquisition. Shares fell on results that missed consensus and indications that legacy franchises were outperforming newer product launches, calling into question AbbVie’s long-term strategy. With promising assets in the pipeline and its robust cash flow profile, we believe AbbVie will grow well into the future.”

6. ProShares Ultra Utilities (NYSEARCA:UPW)

Leverage: 2x

YTD Return as of December 9: -4.50%

The ProShares Ultra Utilities (NYSEARCA:UPW) aims to deliver 2 times the daily returns of the Dow Jones U.S. Utilities Index via a full replication technique. The fund makes use of derivatives, such as swaps, to structure its portfolio. The fund has an expense ratio of 0.95% and a yield of 1.44%. The fund has $16.15 million in assets under management. The fund has lost 4.50% year to date, as of December 9, and has outperformed the S&P 500 by over 10%, and is therefore ranked among the best performing leveraged ETFs in 2022.

The ProShares Ultra Utilities (NYSEARCA:UPW) has 58 holdings and a top ten holdings concentration of 153.92%. The Southern Company (NYSE:SO) is one of the fund’s top holdings. The Southern Company (NYSE:SO) has gained more than 5% over the past twelve months, as of December 9, and is offering a dividend yield of 3.90%.

This October, Guggenheim analyst Shahriar Pourreza updated his price target on The Southern Company (NYSE:SO) to $69 from $80 and maintained a Buy rating on the shares.

As of the end of Q3 2022, Renaissance Technologies is the largest stockholder in The Southern Company (NYSE:SO) and has a position worth $208.2 million.

For risk-averse investors, leveraged ETFs might not be as suitable as individual stocks that are backed by solid fundamentals and healthy financial resources. Some leading companies with solid fundamentals that investors might be interested in studying include Johnson & Johnson (NYSE:JNJ), Northrop Grumman Corporation (NYSE:NOC), and ConocoPhillips (NYSE:COP).

Click to continue reading and see 5 Best Performing Leveraged ETFs in 2022.

AI, Tariffs, Nuclear Power: One Undervalued Stock Connects ALL the Dots (Before It Explodes!)

Published on June 23, 2025 at by Inan Dogan, PhD

Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!

AI is eating the world—and the machines behind it are ravenous.

Each ChatGPT query, each model update, each robotic breakthrough consumes massive amounts of energy. In fact, AI is already pushing global power grids to the brink.

Wall Street is pouring hundreds of billions into artificial intelligence—training smarter chatbots, automating industries, and building the digital future. But there’s one urgent question few are asking:

Where will all of that energy come from?

AI is the most electricity-hungry technology ever invented. Each data center powering large language models like ChatGPT consumes as much energy as a small city. And it’s about to get worse.

Even Sam Altman, the founder of OpenAI, issued a stark warning:

“The future of AI depends on an energy breakthrough.”

Elon Musk was even more blunt:

“AI will run out of electricity by next year.”

As the world chases faster, smarter machines, a hidden crisis is emerging behind the scenes. Power grids are strained. Electricity prices are rising. Utilities are scrambling to expand capacity.

And that’s where the real opportunity lies…

One little-known company—almost entirely overlooked by most AI investors—could be the ultimate backdoor play. It’s not a chipmaker. It’s not a cloud platform. But it might be the most important AI stock in the US owns critical energy infrastructure assets positioned to feed the coming AI energy spike.

As demand from AI data centers explodes, this company is gearing up to profit from the most valuable commodity in the digital age: electricity.

The “Toll Booth” Operator of the AI Energy Boom

It owns critical nuclear energy infrastructure assets, positioning it at the heart of America’s next-generation power strategy.
It’s one of the only global companies capable of executing large-scale, complex EPC (engineering, procurement, and construction) projects across oil, gas, renewable fuels, and industrial infrastructure.
It plays a pivotal role in U.S. LNG exportation—a sector about to explode under President Trump’s renewed “America First” energy doctrine.

Trump has made it clear: Europe and U.S. allies must buy American LNG.

And our company sits in the toll booth—collecting fees on every drop exported.

But that’s not all…

As Trump’s proposed tariffs push American manufacturers to bring their operations back home, this company will be first in line to rebuild, retrofit, and reengineer those facilities.

AI. Energy. Tariffs. Onshoring. This One Company Ties It All Together.

While the world is distracted by flashy AI tickers, a few smart investors are quietly scooping up shares of the one company powering it all from behind the scenes.

AI needs energy. Energy needs infrastructure.

And infrastructure needs a builder with experience, scale, and execution.

This company has its finger in every pie—and Wall Street is just starting to notice.

Wall Street is noticing this company also because it is quietly riding all of these tailwinds—without the sky-high valuation.

While most energy and utility firms are buried under mountains of debt and coughing up hefty interest payments just to appease bondholders…

This company is completely debt-free.

In fact, it’s sitting on a war chest of cash—equal to nearly one-third of its entire market cap.

It also owns a huge equity stake in another red-hot AI play, giving investors indirect exposure to multiple AI growth engines without paying a premium.

And here’s what the smart money has started whispering…

The Hedge Fund Secret That’s Starting to Leak Out

This stock is so off-the-radar, so absurdly undervalued, that some of the most secretive hedge fund managers in the world have begun pitching it at closed-door investment summits.

They’re sharing it quietly, away from the cameras, to rooms full of ultra-wealthy clients.

Why? Because excluding cash and investments, this company is trading at less than 7 times earnings.

And that’s for a business tied to:

The AI infrastructure supercycle
The onshoring boom driven by Trump-era tariffs
A surge in U.S. LNG exports
And a unique footprint in nuclear energy—the future of clean, reliable power

You simply won’t find another AI and energy stock this cheap… with this much upside.

This isn’t a hype stock. It’s not riding on hope.

It’s delivering real cash flows, owns critical infrastructure, and holds stakes in other major growth stories.

This is your chance to get in before the rockets take off!

Disruption is the New Name of the Game: Let’s face it, complacency breeds stagnation.

AI is the ultimate disruptor, and it’s shaking the foundations of traditional industries.

The companies that embrace AI will thrive, while the dinosaurs clinging to outdated methods will be left in the dust.

As an investor, you want to be on the side of the winners, and AI is the winning ticket.

The Talent Pool is Overflowing: The world’s brightest minds are flocking to AI.

From computer scientists to mathematicians, the next generation of innovators is pouring its energy into this field.

This influx of talent guarantees a constant stream of groundbreaking ideas and rapid advancements.

By investing in AI, you’re essentially backing the future.

The future is powered by artificial intelligence, and the time to invest is NOW.

Don’t be a spectator in this technological revolution.

Dive into the AI gold rush and watch your portfolio soar alongside the brightest minds of our generation.

This isn’t just about making money – it’s about being part of the future.

So, buckle up and get ready for the ride of your investment life!

Act Now and Unlock a Potential 100+% Return within 12 to 24 months.

We’re now offering month-to-month subscriptions with no commitments.

For a ridiculously low price of just $9.99 per month, you can unlock our in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s why this is a deal you can’t afford to pass up:

Access to our Detailed Report on our AI, Tariffs, and Nuclear Energy Stock with 100+% potential upside within 12 to 24 months
BONUS REPORT on our #1 AI-Robotics Stock with 10000% upside potential: Our in-depth report dives deep into our #1 AI/robotics stock’s groundbreaking technology and massive growth potential.
One New Issue of Our Premium Readership Newsletter: You will also receive one new issue per month and at least one new stock pick per month from our monthly newsletter’s portfolio over the next 12 months. These stocks are handpicked by our research director, Dr. Inan Dogan.
One free upcoming issue of our 70+ page Quarterly Newsletter: A value of $149
Bonus Content: Premium access to members-only fund manager video interviews
Ad-Free Browsing: Enjoy a month of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.
Lifetime Price Guarantee: Your renewal rate will always remain the same as long as your subscription is active.
30-Day Money-Back Guarantee: If you’re not absolutely satisfied with our service, we’ll provide a full refund within 30 days, no questions asked.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $9.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Subscribe Now!

No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a month later!

Insider Monkey Ads

A New Dawn is Coming to U.S. Stocks

Published on June 13, 2025 at by Insider Monkey Staff

I work for one of the largest independent financial publishers in the world – representing over 1 million people in 148 countries.

We’re independently funding today’s broadcast to address something on the mind of every investor in America right now…

Should I put my money in Artificial Intelligence?

Here to answer that for us… and give away his No. 1 free AI recommendation… is 50-year Wall Street titan, Marc Chaikin.

Marc’s been a trader, stockbroker, and analyst. He was the head of the options department at a major brokerage firm and is a sought-after expert for CNBC, Fox Business, Barron’s, and Yahoo! Finance…

But what Marc’s most known for is his award-winning stock-rating system. Which determines whether a stock could shoot sky-high in the next three to six months… or come crashing down.

That’s why Marc’s work appears in every Bloomberg and Reuters terminal on the planet…

And is still used by hundreds of banks, hedge funds, and brokerages to track the billions of dollars flowing in and out of stocks each day.

He’s used this system to survive nine bear markets… create three new indices for the Nasdaq… and even predict the brutal bear market of 2022, 90 days in advance.

Click to continue reading…

Insider Monkey Ads

Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Log In

Sign Up

10 Best Performing Leveraged ETFs in 2022

Published on December 13, 2022 at 6:47 pm by Omer Farooq in ETF Trading, News

What Are Leveraged ETFs?

It’s a Two Way Street

Best Performing Leveraged ETFs in 2022

10. ProShares Ultra Basic Materials (NYSEARCA:UYM)

9. Direxion Daily Healthcare Bull 3X Shares (NYSEARCA:CURE)

8. Direxion Daily Utilities Bull 3X Shares (NYSEARCA:UTSL)

7. ProShares Ultra Health Care (NYSEARCA:RXL)

6. ProShares Ultra Utilities (NYSEARCA:UPW)

AI, Tariffs, Nuclear Power: One Undervalued Stock Connects ALL the Dots (Before It Explodes!)

Published on June 23, 2025 at by Inan Dogan, PhD

Here’s why this is a deal you can’t afford to pass up:

A New Dawn is Coming to U.S. Stocks

Published on June 13, 2025 at by Insider Monkey Staff